Home | Business News | CBJ Newsmakers | IntelGenx Receives Complete Response Letter from FDA for RIZAPORT® NDA IntelGenx Receives Complete Response Letter from FDA for RIZAPORT® NDA CBJ Newsmakers RecommendedAmerican Lithium Completes Merger with PlateauSavaria Announces 2021 Q1 Results: Revenue up 27% and Adjusted EBITDA up 40%IntelGenx Announces Shareholder Approval of atai Investment
